Key challenges when dealing with vaccine innovation, technology and partnerships in emerging markets

I recently posed this question on LinkedIn, where industry professionals had a chance to discuss and answer the question.  Take a look at the discussion that took place below.  Do you have any challenges that didn't make this discussion?  Comment below and share.  Alternatively, join our Vaccine Nation LinkedIn group for similar conversations. The conversation took place between: Andrew Lees, …

The Promise of Global Symmetry

"We must avoid the unacceptable risk of allowing innovation to foster inequalities," declared Carlos Gadelha, Secretary of Science, Technology, and Strategic Inputs, Ministry of Health, Brazil.   To ensure equity across income strata, he urged his peers to engage in innovative partnerships, buttressed by significant investment, and—most importantly—to think big. Through large-scale initiatives, he continued, "We can induce ‘global symmetry' …